Cobas Asset Management, SGIIC, SA
+5.86%
3個月報酬率
$4.970
0.000 (0.00%)收盤時
ICL Group Ltd, formerly known as Israel Chemicals Ltd, is an Israel-based company, which is engaged in the fertilizer and specialty chemical sectors. The Company operates in three segments: Fertilizers, Industrial Products, and Performance Products. The Fertilizers segment is engaged in the production of standard, granular, fine red and white potash from different sources, as well as in the production of phosphates, such as phosphate rock, phosphoric acid, fertilizers and animal feed addictives. The Industrial Products segment produces flame retardants, such as brominates and organ phosphorus, elemental bromine, and other chemicals. The Performance Products segment produces specialty phosphates, such as technical, food grade and electronic grade phosphoric acid, phosphate salts, food additives and wildfire safety products, as well as alumina and other chemicals.
ICL Group Ltd is currently trading at $4.97, which is below the analyst price target of $6, suggesting potential upside. However, the RSI is at 35.769, indicating that the stock is nearing oversold territory, but the recent 20-day change is down 7.28%, reflecting a bearish trend. The forward P/E ratio is high at 55.5556, which may indicate overvaluation risks in the near term. The company has raised its dividend to $0.0581 per share, yielding 4.51%, which is a positive sign for long-term investors, but the recent net income decline in Q4 2025 to -73 million USD poses a risk. Overall, while there are positive indicators such as the dividend increase and strong sales growth of 17% year-over-year, the stock's recent performance and high valuation metrics suggest caution for new buyers.
Morgan Stanley
—
2026-08-10
Morgan Stanley
2026-08-10
目標價
—
Barclays
$6
2026-07-27
Barclays
2026-07-27
目標價
$6
Morgan Stanley
—
2026-05-28
Morgan Stanley
2026-05-28
目標價
—
Barclays
$7
2026-05-18
Barclays
2026-05-18
目標價
$7
Barclays
$6
2025-11-13
Barclays
2025-11-13
目標價
$6

ICL (ICL) Q2 2026 Earnings Call Transcript

ICL Group Reports Strong Q2 2026 Earnings with Strategic Changes

ICL Group Raises Quarterly Dividend to $0.0581

ICL Group Q2 Earnings Beat Expectations

ICL Reports Best Quarterly Operating Income in Three Years
ICL Group Ltd, formerly known as Israel Chemicals Ltd, is an Israel-based company, which is engaged in the fertilizer and specialty chemical sectors. The Company operates in three segments: Fertilizers, Industrial Products, and Performance Products. The Fertilizers segment is engaged in the production of standard, granular, fine red and white potash from different sources, as well as in the production of phosphates, such as phosphate rock, phosphoric acid, fertilizers and animal feed addictives. The Industrial Products segment produces flame retardants, such as brominates and organ phosphorus, elemental bromine, and other chemicals. The Performance Products segment produces specialty phosphates, such as technical, food grade and electronic grade phosphoric acid, phosphate salts, food additives and wildfire safety products, as well as alumina and other chemicals. It operates in the Basic Materials sector.
ICL Group Ltd is currently trading at $4.97, which is below the analyst price target of $6, suggesting potential upside. However, the RSI is at 35.769, indicating that the stock is nearing oversold territory, but the recent 20-day change is down 7.28%, reflecting a bearish trend. The forward P/E ratio is high at 55.5556, which may indicate overvaluation risks in the near term. The company has raised its dividend to $0.0581 per share, yielding 4.51%, which is a positive sign for long-term investors, but the recent net income decline in Q4 2025 to -73 million USD poses a risk. Overall, while there are positive indicators such as the dividend increase and strong sales growth of 17% year-over-year, the stock's recent performance and high valuation metrics suggest caution for new buyers.
3 analysts cover ICL: 0 rate it Buy, 3 Hold and 0 Sell. The average price target is 6.18.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。